サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1279739

ライム病診断の世界市場規模調査＆予測、新興診断技術別、エンドユーザー別、地域別分析、2022-2029年

Global Lyme Disease Diagnostic Market Size study & Forecast, by Emerging Diagnostic Technology, by End User and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ライム病診断の世界市場規模調査＆予測、新興診断技術別、エンドユーザー別、地域別分析、2022-2029年
出版日: 2023年05月13日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ライム病は、Borrelia burgdorferiによって引き起こされる細菌感染症です。

感染したクロマダニに咬まれることでヒトに感染します。ライム病の症状は、インフルエンザのような症状、発熱、疲労感など他の病気と似ていることがあり、診断が困難です。ライム病の初期には、片頭痛紅斑という特徴的な発疹が出ることがあります。しかし、すべての患者がこの発疹を発症するわけではなく、ライム病は後期になると神経系、心臓、関節に影響を及ぼすことがあります。市場成長の主な要因は、ライム病の有病率の増加、ヘルスケア施設に対する政府の好意的な取り組み、新しいライム病診断テストの出現であり、これらは予測期間中に市場に対する有利な需要を生み出すと予想されます。

さらに、ライム病の有病率の上昇は、市場にとって有利な需要を生み出すと予想されています。例えば、Centres for Disease Control and Preventionによると、2021年には47,743件のダニ媒介性疾患患者が報告されており、これがライム病診断テストの開発につながっています。別の例として、米国公正保健機構は2022年に、ライム病が米国で過去15年間に大幅に増加し、その結果、国の懸念が高まっている状態になったと発表しました。同じソースによると、ライム病診断のための民間保険請求ラインは、2021年に過去10年間と比較して、地方で357％、都市部で65％増加しました。さらに、ライム病診断の研究開発の高まりは、予測期間中に市場に有利な機会を生み出すと予想されます。しかし、この病気に関する認知度の低さが、2022年から2029年の予測期間を通じて市場の成長を阻害しています。

ライム病診断の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。北米は、主要な市場プレイヤーの存在と、様々な疾患の診断と治療のための政府の一貫した取り組みにより、市場シェアにおいて世界の主要な地域となっています。一方、アジア太平洋地域は、ライム病患者の増加、より良い診断システムのための医療分野への公的・民間投資の増加などの要因により、予測期間中に高い成長率を示すと予想され、アジア太平洋地域のライム病診断市場にとって有利な成長見通しを生み出しています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推計・予測、2019年～2029年
    • ライム病診断市場、地域別、2019年-2029年
    • ライム病診断市場：新興診断技術別、2019年-2029年
    • ライム病診断市場：エンドユーザー別、2019年-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 ライム病診断の世界市場の定義と範囲

  • 本調査の目的
  • 市場の定義と範囲
    • 本調査の対象範囲
    • 産業の進化
  • 調査対象年
  • 通貨換算レート

第3章 ライム病診断の世界市場力学

  • ライム病診断薬市場の影響分析（2019年～2029年）
    • 市場促進要因
      • ライム病の有病率の増加
      • ヘルスケア施設に対する政府の好意的な取り組み
      • 新しいライム病診断検査の登場
    • 市場の課題
      • ライム病に関する認識不足
    • 市場機会
      • ライム病診断の研究開発の活発化

第4章 ライム病診断の世界市場の産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルの未来的アプローチ（2019年～2029年）
  • PEST分析
    • 政治的
    • 経済的
    • 社会的
    • 技術的
  • 主な投資機会
  • 主要成功戦略
  • 業界専門家別展望
  • アナリストの結論・提言

第5章 リスクアセスメントCOVID-19の影響

  • COVID-19が業界に与える全体的な影響についてのアセスメント
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 ライム病診断の世界市場、新興診断技術別

  • 市場スナップショット
  • ライム病診断の世界市場、新興診断技術別、実績 - ポテンシャル分析
  • ライム病診断の世界市場、新興診断技術別推定・予測2019-2029
  • ライム病診断市場、サブセグメント別分析
    • 血清学的検査
    • 尿中抗原検査
    • リンパ球変質検査
    • 免疫蛍光染色法
    • 核酸検査

第7章 ライム病診断の世界市場：エンドユーザー別

  • 市場スナップショット
  • ライム病診断の世界市場：エンドユーザー別、実績 - ポテンシャル分析
  • ライム病診断の世界市場、エンドユーザー別、推定・予測2019-2029
  • ライム病診断薬市場、サブセグメント別分析
    • 病院
    • 公的/私的ラボラトリー
    • 医師事務所

第8章 ライム病診断の世界市場：地域別分析

  • ライム病診断薬市場、地域別市場スナップショット
  • 北米
    • 米国
      • 新興診断技術別の推定・予測、2019年～2029年
      • エンドユーザー別の推定・予測、2019年～2029年
    • カナダ
  • 欧州ライム病診断市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋地域のライム病診断市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのライム病診断市場スナップショット
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域
  • 世界のその他の地域

第9章 競合情報

  • 主な市場戦略
  • 企業プロファイル
    • Abbott Laboratories
      • 主要情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • T2 Biosystems
    • Canon Life Sciences
    • Bio Rad Laboratories
    • Alere Inc.
    • Roche Diagnostics International Ltd.
    • Graphene Frontiers
    • Covance Inc.
    • Immunetics Inc.
    • GlaxoSmithKline

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Lyme Disease Diagnostic Market, report scope
  • TABLE 2. Global Lyme Disease Diagnostic Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Lyme Disease Diagnostic Market estimates & forecasts by Emerging Diagnostic Technology 2019-2029 (USD Billion)
  • TABLE 4. Global Lyme Disease Diagnostic Market estimates & forecasts by End User 2019-2029 (USD Billion)
  • TABLE 5. Global Lyme Disease Diagnostic Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Lyme Disease Diagnostic Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Lyme Disease Diagnostic Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Lyme Disease Diagnostic Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Lyme Disease Diagnostic Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Lyme Disease Diagnostic Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Lyme Disease Diagnostic Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Lyme Disease Diagnostic Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Lyme Disease Diagnostic Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Lyme Disease Diagnostic Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Lyme Disease Diagnostic Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Lyme Disease Diagnostic Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Lyme Disease Diagnostic Market
  • TABLE 70. List of primary sources, used in the study of global Lyme Disease Diagnostic Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Lyme Disease Diagnostic Market, research methodology
  • FIG 2. Global Lyme Disease Diagnostic Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Lyme Disease Diagnostic Market, key trends 2021
  • FIG 5. Global Lyme Disease Diagnostic Market, growth prospects 2022-2029
  • FIG 6. Global Lyme Disease Diagnostic Market, porters 5 force model
  • FIG 7. Global Lyme Disease Diagnostic Market, pest analysis
  • FIG 8. Global Lyme Disease Diagnostic Market, value chain analysis
  • FIG 9. Global Lyme Disease Diagnostic Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Lyme Disease Diagnostic Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Lyme Disease Diagnostic Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Lyme Disease Diagnostic Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Lyme Disease Diagnostic Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Lyme Disease Diagnostic Market, regional snapshot 2019 & 2029
  • FIG 15. North America Lyme Disease Diagnostic Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Lyme Disease Diagnostic Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Lyme Disease Diagnostic Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Lyme Disease Diagnostic Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Lyme Disease Diagnostic Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Lyme Disease Diagnostic Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Lyme disease is a bacterial infection caused by Borrelia burgdorferi. It is transmitted to humans through the bite of an infected black-legged tick. The symptoms of Lyme disease can be similar to other illnesses such as flu-like symptoms, fever, and fatigue, making it difficult to diagnose. In the early stages of Lyme disease, a characteristic rash called erythema migraines may develop. However, not all patients develop this rash, and in later stages, Lyme disease can affect the nervous system, heart, and joints. The key factor driving the market growth is growing prevalence of Lyme disease, favorable government initiative towards healthcare facilities, and emergence of new Lyme diagnostic tests that anticipated to create the lucrative demand for the market during forecast period.

Moreover, the rise in prevalence of Lyme disease is anticipated to create the lucrative demand for the market. For instance, according to the Centres for Disease Control and Prevention, there were 47,743 tick-borne disease cases reported in 2021, which led the development of Lyme disease diagnostic tests. For another example, the United States Fair Health Organization announced in 2022 that Lyme disease had increased significantly over the previous 15 years in the United States and had consequently become a condition of rising national concern. According to the same source, private insurance claim lines for Lyme disease diagnosis increased by 357 percent in rural areas and by 65 percent in urban areas in 2021 compared to the previous ten years. Additionally, the rising research and development in Lyme disease diagnostic is anticipated to create the lucrative opportunity for the market during forecast period. However, the lack of awareness regarding the disease stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Lyme Disease Diagnostic Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, and cohesive government initiatives for diagnosing and treatment of various diseases. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as rising Lyme disease cases and growing public and private investment in healthcare sector for better diagnostics system would create lucrative growth prospects for the Lyme Disease Diagnostic market across Asia Pacific region.

Major market players included in this report are:

  • Abbott Laboratories
  • T2 Biosystems
  • Canon Life Sciences
  • Bio Rad Laboratories
  • Alere Inc.
  • Roche Diagnostics International Ltd.
  • Graphene Frontiers
  • Covance Inc.
  • Immunetics Inc.
  • GlaxoSmithKline

Recent Developments in the Market:

  • In July, 2022, the United States Food and Drug Administration (USFDA) approved T2Biosystems and T2Lyme Panel. The T2Lyme Panel is intended to enable more precise early Lyme disease diagnosis, which may help to enhance care and improve patient outcomes. The T2Lyme Panel uses a patient's blood to identify bacteria that cause Lyme disease.

Global Lyme Disease Diagnostic Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Emerging Diagnostic Technology, End User, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Emerging Diagnostic Technology:

  • Serological Test
  • Urine Antigen Tests
  • Lymphocytic Transformation Test
  • Immunofluorescent Staining
  • Nucleic acid Test

By End User:

  • Hospitals
  • Public/Private Laboratories
  • Physicians Office

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Lyme Disease Diagnostic Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Lyme Disease Diagnostic Market, by Emerging Diagnostic Technology, 2019-2029 (USD Billion)
    • 1.2.3. Lyme Disease Diagnostic Market, by End User, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Lyme Disease Diagnostic Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Lyme Disease Diagnostic Market Dynamics

  • 3.1. Lyme Disease Diagnostic Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of Lyme disease
      • 3.1.1.2. Favorable government initiative towards healthcare facilities
      • 3.1.1.3. Emergence of new Lyme diagnostic tests
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness regarding the disease
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising research and development in Lyme disease diagnostic

Chapter 4. Global Lyme Disease Diagnostic Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Lyme Disease Diagnostic Market, by Emerging Diagnostic Technology

  • 6.1. Market Snapshot
  • 6.2. Global Lyme Disease Diagnostic Market by Emerging Diagnostic Technology, Performance - Potential Analysis
  • 6.3. Global Lyme Disease Diagnostic Market Estimates & Forecasts by Emerging Diagnostic Technology 2019-2029 (USD Billion)
  • 6.4. Lyme Disease Diagnostic Market, Sub Segment Analysis
    • 6.4.1. Serological Test
    • 6.4.2. Urine Antigen Tests
    • 6.4.3. Lymphocytic Transformation Test
    • 6.4.4. Immunofluorescent Staining
    • 6.4.5. Nucleic acid Test

Chapter 7. Global Lyme Disease Diagnostic Market, by End User

  • 7.1. Market Snapshot
  • 7.2. Global Lyme Disease Diagnostic Market by End User, Performance - Potential Analysis
  • 7.3. Global Lyme Disease Diagnostic Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
  • 7.4. Lyme Disease Diagnostic Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Public/Private Laboratories
    • 7.4.3. Physicians Office

Chapter 8. Global Lyme Disease Diagnostic Market, Regional Analysis

  • 8.1. Lyme Disease Diagnostic Market, Regional Market Snapshot
  • 8.2. North America Lyme Disease Diagnostic Market
    • 8.2.1. U.S. Lyme Disease Diagnostic Market
      • 8.2.1.1. Emerging Diagnostic Technology breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Lyme Disease Diagnostic Market
  • 8.3. Europe Lyme Disease Diagnostic Market Snapshot
    • 8.3.1. U.K. Lyme Disease Diagnostic Market
    • 8.3.2. Germany Lyme Disease Diagnostic Market
    • 8.3.3. France Lyme Disease Diagnostic Market
    • 8.3.4. Spain Lyme Disease Diagnostic Market
    • 8.3.5. Italy Lyme Disease Diagnostic Market
    • 8.3.6. Rest of Europe Lyme Disease Diagnostic Market
  • 8.4. Asia-Pacific Lyme Disease Diagnostic Market Snapshot
    • 8.4.1. China Lyme Disease Diagnostic Market
    • 8.4.2. India Lyme Disease Diagnostic Market
    • 8.4.3. Japan Lyme Disease Diagnostic Market
    • 8.4.4. Australia Lyme Disease Diagnostic Market
    • 8.4.5. South Korea Lyme Disease Diagnostic Market
    • 8.4.6. Rest of Asia Pacific Lyme Disease Diagnostic Market
  • 8.5. Latin America Lyme Disease Diagnostic Market Snapshot
    • 8.5.1. Brazil Lyme Disease Diagnostic Market
    • 8.5.2. Mexico Lyme Disease Diagnostic Market
    • 8.5.3. Rest of Latin America Lyme Disease Diagnostic Market
  • 8.6. Rest of The World Lyme Disease Diagnostic Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Abbott Laboratories
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. T2 Biosystems
    • 9.2.3. Canon Life Sciences
    • 9.2.4. Bio Rad Laboratories
    • 9.2.5. Alere Inc.
    • 9.2.6. Roche Diagnostics International Ltd.
    • 9.2.7. Graphene Frontiers
    • 9.2.8. Covance Inc.
    • 9.2.9. Immunetics Inc.
    • 9.2.10. GlaxoSmithKline

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption